European Commission approves Sarclisa for adults with relapsed and refractory multiple myeloma Read more
Memo Therapeutics AG Identifies Potent SARS-CoV-2-Neutralizing Antibodies From the Blood of Recovered COVID-19 Patients Read more
Octapharma USA extends funding for COVID-19 study following positive preliminary research data Read more
Janssen’s TREMFYA delivers improvement in psoriatic arthritis joint and skin symptoms at week 52 in phase 3 trials Read more